Porcel Pérez, J. M., Ferreiro, L., Rumi, L., Espino Paisán, E., Civit, C., Pardina Solano, M. A., . . . Bielsa Martín, S. (2020). Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial.

Porcel Pérez, José Manuel, Lucía Ferreiro, Laura Rumi, Esther Espino Paisán, Carmen Civit, Marina Asunción Pardina Solano, Joan Antoni Schoenenberger, Luis Valdés, and Silvia Bielsa Martín. Two Vs. Three Weeks of Treatment With Amoxicillin-clavulanate for Stabilized Community-acquired Complicated Parapneumonic Effusions. A Preliminary Non-inferiority, Double-blind, Randomized, Controlled Trial. 2020.

Porcel Pérez, José Manuel, et al. Two Vs. Three Weeks of Treatment With Amoxicillin-clavulanate for Stabilized Community-acquired Complicated Parapneumonic Effusions. A Preliminary Non-inferiority, Double-blind, Randomized, Controlled Trial. 2020.